Skip to main content
Psychedelic State(s) of America
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices
Back to the NewsWire

Psychedelicalpha

Published November 2, 2026 · Updated November 3, 2026

Podcast: Usona Files Psilocybin Application, We Review 610 Comments Submitted to FDA ...

Read the full story at Psychedelicalpha

In this episode of The Psychedelic News Feed podcast, Psychedelic Alpha's editor Josh Hardman runs through the last two weeks in the psychedelics.

Post on X

Share this story

Share on XShare on LinkedInShare on FacebookShare on WhatsAppShare on Signal

Surfaced by this Google Alert

  • Psychedelics